Trilantic Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.29M Sell
23,061
-5,927
-20% -$297K 1.57% 6
2022
Q2
$1.29M Sell
28,988
-12,565
-30% -$645K 1.22% 7
2022
Q1
$2.35M Buy
+41,553
New +$2.17M 1.07% 6

Other funds holding EHC

Trilantic Capital Management's EHC Position: Q3 2022 in Review

Trilantic Capital Management reduced its Encompass Health (EHC) stake by 20% in Q3 2022, selling an estimated $297K and leaving 23,061 shares worth $1.29M. The position accounts for 1.57% of the portfolio, ranked #6.

Trilantic Capital Management first reported a position in EHC in Q1 2022 and has held it in 3 quarters since. The position peaked at $2.35M in Q1 2022. 347 funds tracked by Wall St. Rank hold EHC as of Q3 2022.

  • Trilantic Capital Management held 23,061 shares of Encompass Health worth $1.29M as of Q3 2022.
  • Trilantic Capital Management sold 5,927 Encompass Health shares in Q3 2022, an estimated $297K.
  • Encompass Health made up 1.57% of Trilantic Capital Management's portfolio in Q3 2022, its #6 holding.
  • Trilantic Capital Management first reported a position in Encompass Health in Q1 2022 and has held it in 3 quarters since.
  • Trilantic Capital Management's Encompass Health position peaked at $2.35M in Q1 2022.
  • 347 funds tracked by Wall St. Rank held Encompass Health as of Q3 2022.

Based on Trilantic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.